Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients
- 1 October 1999
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 13 (14) , 1978-80
- https://doi.org/10.1097/00002030-199910010-00023
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- A Multicenter Phase I/II Dose Escalation Study of Single-Dose Cidofovir Gel for Treatment of Recurrent Genital HerpesAntimicrobial Agents and Chemotherapy, 1998
- Topical and intralesional cidofovir: A review of pharmacology and therapeutic effectsJournal of the American Academy of Dermatology, 1998
- Imiquimod 5% cream (Aldara™)Expert Opinion on Investigational Drugs, 1998
- Treating sexually transmitted diseases to control HIV transmissionCurrent Opinion in Infectious Diseases, 1997
- Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in womenAIDS, 1993